In the search for yield, investors are increasingly looking past traditional fixed income benchmarks and into the $3 trillion private credit market. However, for many, the barriers to entry — ranging from high investment minimums to illiquidity and complex tax reporting — have made the asset class difficult to navigate.
See more: Navigating Private Credit: Simplify’s Christopher Getter on PCR
The launch of the Simplify Private Credit Strategy ETF (PCR) represents a pivotal shift in this landscape. Designed to democratize access to the asset class, PCR offers a liquid, ETF-wrapped solution that seeks to capture the high-yield potential of private markets while mitigating the inherent risks through a unique structural approach.
Navigating Private Credit With PCR
PCR does not invest directly in private loans, which would violate the liquidity requirements of the ETF structure. Instead, it utilizes total return swaps to gain exposure to the VettaFi Private Credit Index. This index tracks a diversified basket of publicly traded Business Development Companies (BDCs) and Closed-End Funds (CEFs) that have at least 50% of their portfolios dedicated to private credit.
By leveraging BDCs and CEFs, PCR provides exposure to the middle market lending that defines the private credit boom. These vehicles often yield significantly more than traditional high-yield bonds, making them attractive for income-oriented portfolios.
Managing the Downside: The Credit Hedge
Recognizing that private credit is sensitive to economic downturns and widening credit spreads, PCR incorporates a proprietary quality-junk credit hedge. This strategy involves a long/short overlay: going long on quality equities with strong balance sheets while shorting junk equities that are highly sensitive to refinancing costs. This buffer may provide resilience during periods of market stress, offering a smoother ride for investors.
As the 60/40 portfolio continues to face challenges, PCR stands out as a sophisticated tool for advisors looking to enhance income. For income investors, it’s not just about finding yield — it’s about finding it with the liquidity and transparency that the ETF wrapper can provide.
For more news, information, and analysis, visit the Institutional Income Strategies Content Hub.
VettaFi.com is owned by VettaFi LLC (“VettaFi”). VettaFi is the index provider for PCR, for which it receives an index licensing fee. However, PCR is not issued, sponsored, endorsed, or sold by VettaFi. VettaFi has no obligation or liability in connection with the issuance, administration, marketing, or trading of PCR.
